REFERENCES
- Almeida A. J., Runge S., Muller R. H. Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int. J. Pharm. 1997; 149: 255–265
- Siekmann B., Westesen K. Submicron-sized parental carrier system based on solid lipids. Pharm. Pharmacol. Lett. 1992; 1: 123–126
- Boltri L., Canal T., Esposito P. A., Carli F. Lipid nanoparticles: evaluation of some critical formulation parameters. Proc. Int. Symp. Control. Rel. Bioact. Mater. 1993; 20: 346–347
- Sjostrom B., Bergenstahl B. Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate. Int. J. Pharm. 1992; 88: 53–62, [CROSSREF]
- Muller R. H., Mehnert W., Lucks J. S., Schwarz C., Zur Muhlen A., Weyhers H., Freitas C., Ruhl D. Solid lipid nanoparticle (SLN) an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 1995; 41: 62–69
- Schwarz C., Mehnert W., Lucks J. S., Muller R. H. Solid lipid nanoparticle (SLN) for controlled drug delivery I production, characterization and sterlization. J. Control. Rel. 1994; 30: 83–96, [CROSSREF]
- Schwarz C., Mehnert W. Freeze drying of drug free and drug loaded solid lipid nanoparticle (SLN). Int. J. Pharm. 1997; 157: 171–179, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Heiati H., Tawashi R., Phillips N. C. Drug retention and stability of solid lipid nanoparticle containing azidothymidine palmitate after autoclaving, storage and lyophilization. J. Microencapsul. 1998; 15: 173–184, [PUBMED], [INFOTRIEVE], [CSA]
- Muller R. H., Dingler A. The next generation after the liposomes: solid lipid nanoparticle (SLN/Lipopearls) as dermal carrier in cosmetics. Euro. Cosmet. 1998; 718: 19–26
- Muller R. H., Maaßen S., Weyhers H., Specht F., Lucks J. S. Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int. J. Pharm. 1996; 138: 85–94, [CROSSREF]
- Wester R., Patel R., Nacht S., Leyden J., Melendres J., Maibach H. Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. J. Am. Acad. Dermatol. 1991; 24: 720–726, [PUBMED], [INFOTRIEVE]
- Masini V., Bonte F., Meybeck A., Wepierre J. Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. J. Pharm. Sci. 1993; 82: 17–21, [PUBMED], [INFOTRIEVE]
- Schafer-Korting M., Korting H. C., Ponce-Poschl E. Liposomal tretinoin for uncomplicated acne vulgaris. Clin. Invest. 1994; 72: 1086–1096, [CROSSREF]
- Maia C. S., Mehnert W., Schafer-Karting M. Solid lipid nanoparticle as drug carrier for topical glucocorticoids. Int. J. Pharm. 2000; 196: 165–170, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dingler A., Blum R. P., Niehus H., Muller R. H., Gohla S. Solid lipid nanoparticle—a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. J. Microencapsul. 1999; 16: 751–767, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cavalli R., Morel S., Gasco M. R., Chetoni P., Saettone M. F. Preparation and evaluation of in vitro colloidal lipospheres containing pilocarpine as ion pair. Int. J. Pharm. 1995; 117: 243–246, [CROSSREF]
- Gasco M. R. Solid lipid nanospheres from warm microemulsions. Pharm. Tech. Eur. 1997; 9: 52–58
- Boltri L., Canal T., Esposito P. A., Carli F. Lipid nanoparticles: evaluation of some critical formulation parameters. Int. Symp. Control. Rel. Bioact. Mater. 1993; 20: 346–347
- Cavalli R., Marengo E., Rodriguez L., Gasco M. R. Effect of some experimental factors on the production process of solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 1996; 42: 110–115
- Westeren K., Siekmann B. Investigation of the gel formulation of phospholipid-stabilized solid lipid nanoparticles. Int. J. Pharm. 1997; 151: 35–45, [CROSSREF]
- Olbrich C., Muller R. H. Enzymatic degradation of solid lipid nanoparticle effect of surfactant and surfactant mixtures. Int. J. Pharm. 1999; 180: 31, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Siekmann B., Westesen K. Investigation on solid lipid nanoparticles prepared by precipitations in o/w emulsions. Eur. J. Pharm. Biopharm. 1996; 43: 104–109
- Chatterjee C. C. Human Physiology3rd ed. Books & Allied Private Ltd, CalcuttaIndia 1966
- Langer R. S., Peppas A. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 1981; 2: 201–214, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Freitas C., Muller R. H. Correlation between long term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. J. Pharm. Biopharm. 1999; 47: 125–132, [CROSSREF]
- Jenning V., Shafer-Korting M., Gohla S. A loaded solid lipid nanoparticles for topical use: drug release properties. J. Control. Rel. 2000; 66: 115–120, [CROSSREF], [CSA]